Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs)

Autor:	R. Hall, Jacobi Hines, Camilo E. Fadul, Jason P. Sheehan, James M. Larner, Michael Edward Devitt, Ralph Sumner Abraham, Bethany J. Horton, Ryan D. Gentzler
Rok vydání:	2018
Předmět:	Cancer Research Metastatic melanoma business.industry Immune checkpoint inhibitors Melanoma food and beverages non-small cell lung cancer (NSCLC) medicine.disease Oncology medicine Cancer research business Adverse effect neoplasms
Zdroj:	Journal of Clinical Oncology. 36:2010-2010
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.2010
Popis:	2010Background: CPIs are widely used in the treatment of both metastatic melanoma and NSCLC. BM frequently occur and are treated with CNS-RT. Since both CNS-RT and CPIs can cause neuro-inflammation...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fea8bd0ad007c1e6b0cc6c578e4be6db https://doi.org/10.1200/jco.2018.36.15_suppl.2010 Zobrazit plný text záznamu